Shares of Jaguar Animal Health Inc (NASDAQ:JAGX) traded up 5.8% during mid-day trading on Thursday . The company traded as high as $2.25 and last traded at $2.00, with a volume of 308,913 shares. The stock had previously closed at $1.89.

A number of analysts have issued reports on the company. Zacks Investment Research downgraded Jaguar Animal Health from a “hold” rating to a “sell” rating in a research note on Wednesday, May 4th. Feltl & Co. downgraded Jaguar Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, March 30th. Finally, Aegis reaffirmed a “buy” rating and issued a $10.00 price objective on shares of Jaguar Animal Health in a research note on Monday, June 13th.

The company’s market capitalization is $19.68 million. The company has a 50-day moving average price of $1.81 and a 200 day moving average price of $1.88.

Jaguar Animal Health, Inc is an animal health company focused on developing and commercializing gastrointestinal products for companion and production animals, and horses. The Company is developing a pipeline of prescription drug product candidates and non-prescription (non-drug) products. Its pipeline includes prescription drug product candidates for over eight indications across various species and non-prescription products targeting over seven species.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.